- Home
- Publications
- Publication Search
- Publication Details
Title
Management of
NAFLD
in primary care settings
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 42, Issue 11, Pages 2377-2389
Publisher
Wiley
Online
2022-08-21
DOI
10.1111/liv.15404
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials
- (2022) Vincent Wai-Sun Wong et al. Clinical Gastroenterology and Hepatology
- Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes
- (2022) Richeek Pradhan et al. DIABETES CARE
- Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
- (2022) Alessandro Mantovani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A global view of the interplay between non-alcoholic fatty liver disease and diabetes
- (2022) Norbert Stefan et al. Lancet Diabetes & Endocrinology
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Nonalcoholic Fatty Liver Disease and Accelerated Loss of Skeletal Muscle Mass: A Longitudinal Cohort Study
- (2022) Dong Hyun Sinn et al. HEPATOLOGY
- Knowledge of liver fibrosis stage among adults with NAFLD / NASH improves adherence to lifestyle changes
- (2022) Patrizia Carrieri et al. LIVER INTERNATIONAL
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort
- (2021) Miguel H. Malespin et al. Clinical Gastroenterology and Hepatology
- Co-Medication and nutrition in HCC: Potentially preventative strategies in Hepatocellular carcinoma (HCC)
- (2021) Alexander Kusnik et al. DIGESTIVE DISEASES
- Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial
- (2021) Anat Yaskolka Meir et al. GUT
- A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis
- (2021) Shuen Sung et al. BMC GASTROENTEROLOGY
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
- (2021) Chandani Patel Chavez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ultra‐processed food is associated with features of metabolic syndrome and non‐alcoholic fatty liver disease
- (2021) Dana Ivancovsky‐Wajcman et al. LIVER INTERNATIONAL
- PPAR‐γ‐induced Changes in Visceral Fat and Adiponectin Levels are Associated with Improvement of Steatohepatitis in Patients with NASH
- (2021) Amalia Gastaldelli et al. LIVER INTERNATIONAL
- Dietary carbohydrates and fats in nonalcoholic fatty liver disease
- (2021) Hannele Yki-Järvinen et al. Nature Reviews Gastroenterology & Hepatology
- Defining comprehensive models of care for NAFLD
- (2021) Jeffrey V. Lazarus et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
- (2021) Jeffrey V. Lazarus et al. JOURNAL OF HEPATOLOGY
- The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
- (2021) Tom H Karlsen et al. LANCET
- Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
- (2021) V. Ratziu et al. NATURE MEDICINE
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men
- (2021) Naoko Nakanishi et al. Scientific Reports
- Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes
- (2020) Kenneth Cusi DIABETES CARE
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study
- (2020) Hye Won Lee et al. HEPATOLOGY
- Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease
- (2020) Donghee Kim et al. HEPATOLOGY
- Bariatric Surgery is Associated With Decreased Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis
- (2020) Keith M. Wirth et al. ANNALS OF SURGERY
- Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Non-alcoholic Steatohepatitis-related, Child-Pugh A Cirrhosis
- (2020) Eduardo Vilar-Gomez et al. Clinical Gastroenterology and Hepatology
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease
- (2020) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gut microbial metabolites as multi-kingdom intermediates
- (2020) Kimberly A. Krautkramer et al. NATURE REVIEWS MICROBIOLOGY
- Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD
- (2020) V. H. Nguyen et al. JOURNAL OF INTERNAL MEDICINE
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESPEN guideline on clinical nutrition in liver disease
- (2019) Mathias Plauth et al. CLINICAL NUTRITION
- Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
- (2019) Ralph A DeFronzo et al. Diabetes & Vascular Disease Research
- Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis
- (2019) Wah-Kheong Chan et al. Clinical Gastroenterology and Hepatology
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
- (2019) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- (2019) Bhagirath Chaurasia et al. SCIENCE
- Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
- (2019) Sabine Kahl et al. DIABETES CARE
- Diet associations with nonalcoholic fatty liver disease in an ethnically diverse population: the Multiethnic Cohort
- (2019) Mazen Noureddin et al. HEPATOLOGY
- Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2019) Stephen A Harrison et al. LANCET
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Guideline Recommendations for Obesity Management
- (2018) Donna H. Ryan et al. MEDICAL CLINICS OF NORTH AMERICA
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses
- (2018) Jaehee Ahn et al. CLINICAL NUTRITION
- Age-Related Decrease in Skeletal Muscle Mass Is An Independent Risk Factor for Incident NAFLD: A 10-Year Retrospective Cohort Study
- (2018) Min Jung Lee et al. Gut and Liver
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-Analysis
- (2018) Yung Lee et al. Clinical Gastroenterology and Hepatology
- Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
- (2018) Kenneth Cusi et al. DIABETES OBESITY & METABOLISM
- Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis
- (2018) Eduardo Vilar-Gomez et al. HEPATOLOGY
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
- (2017) Shira Zelber-Sagi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
- (2017) Olga Vaccaro et al. Lancet Diabetes & Endocrinology
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
- (2017) Elena Filipova et al. Diabetes Therapy
- Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools
- (2017) Yftach Gepner et al. CIRCULATION
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- (2016) Obesity Facts
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
- (2015) Wilfrid Mazier et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Hypoxia and Adipocyte Physiology: Implications for Adipose Tissue Dysfunction in Obesity
- (2014) Paul Trayhurn Annual Review of Nutrition
- Pleiotropic Roles of Bile Acids in Metabolism
- (2013) Thomas Q. de Aguiar Vallim et al. Cell Metabolism
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Four-Year Weight Losses in the Look AHEAD Study: Factors Associated With Long-Term Success
- (2011) Thomas A. Wadden et al. Obesity
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatty liver and lipotoxicity
- (2009) Michael Trauner et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
- (2008) V. W.-S. WONG et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started